Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma.
Autor: | Alrwas, Anas, Papadopoulos, Nicholas E., Cain, Suzanne, Patel, Sapna P., Kim, Kevin B., Deburr, Tawania L., Bassett Jr, Roland, Hwu, Wen-Jen, Bedikian, Agop Y., Davies, Michael A., Woodman, Scott E., Hwu, Patrick |
---|---|
Zdroj: | Melanoma Research; Aug2014, Vol. 24 Issue 4, p342-348, 7p |
Databáze: | Complementary Index |
Externí odkaz: |